Dehydro Desmethoxy Apixaban - Request Quote
Dehydro Desmethoxy Apixaban
| SZ CAT No: | SZ-A062132 |
| CAS No | NA |
| Mol.F. | C24H21N5O3 |
| Mol.Wt. | 427.5 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Dehydro Desmethoxy Apixaban is chemically 7-Oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-1-phenyl-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide. Dehydro Desmethoxy Apixaban is supplied with detailed characterization data compliant with regulatory guideline. Dehydro Desmethoxy Apixaban can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Dehydro Desmethoxy Apixaban
Purchase Dehydro Desmethoxy Apixaban
Dehydro Desmethoxy Apixaban suppliers
Dehydro Desmethoxy Apixaban manufacturers
Dehydro Desmethoxy Apixaban price
Order Dehydro Desmethoxy Apixaban
Enquire Dehydro Desmethoxy Apixaban
Dehydro Desmethoxy Apixaban cost
Dehydro Desmethoxy Apixaban Supplier
Dehydro Desmethoxy Apixaban Distributor
Dehydro Desmethoxy Apixaban for Method Validation
Apixaban Reference Standard
Dehydro Desmethoxy Apixaban for ANDA Filing
Dehydro Desmethoxy Apixaban for Forced Degradation Studies
Dehydro Desmethoxy Apixaban Identification Standards
Dehydro Desmethoxy Apixaban for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.